Healthcare AI adoption: scope the workflow, data and review
Compare hospital, biotech and care workflows. Define approved data, professional review, failure handling and operating ownership, with Taiwan regulatory sources scoped to the intended use.
By
Tenten AI Delivery Team
Industry Delivery
Published
Updated
Read time
4 min

Healthcare AI adoption starts with a specific task and the person responsible for it. Preparing an administrative form, summarizing approved documents and suggesting a clinical diagnosis have different risks and evidence requirements. Define the intended use before selecting data, reviewers or a deployment approach.
The map below is a planning aid. It does not report client results or establish that an application has medical-device authorization.
Separate the work in three settings
| Setting | Support tasks to assess | Questions before deployment |
|---|---|---|
| Hospitals and clinics | Administrative form preparation, scheduling replies, record summaries for professional review | Who may access the source record? What could an incorrect summary affect? Who verifies the source and decides whether to use the result? |
| Biotech and pharmaceutical teams | Approved-literature retrieval, document drafts, research-data organization | Does the task involve regulated records? How are sources, versions and revisions retained? Which uses need quality-team assessment? |
| Long-term and home care | Scheduling communication, care-record drafts, outstanding-task summaries | Who checks the content? How does staff take over during failure? What authorizes processing of the person's data? |
Use this map to narrow the scope. Administrative work is not automatically low risk, and literature retrieval is not equivalent to clinical decision support.
Hospitals: assess correctness and reviewer workload
Consider an illustrative task: preparing an administrative form from approved records. List permitted fields, source locations, content the system must not infer and the person who checks the draft. Missing information should be marked or referred for manual handling. A plausible guess is not a completed task.
Evaluate incorrect fields, omissions, wrong source references, revisions and review time. The responsible team should record the existing workload, exception cases and quality criteria first. Adoption indicates use; it cannot substitute for evidence of accuracy or safety.
The existing healthcare administration offering provides a starting point for scoping this work. AI Copilot describes supervised support. These service pages do not establish autonomous diagnostic capability or clinical effectiveness.
Biotech: determine the document's use
A literature summary can retain its source, date and relevant passage while distinguishing a research hypothesis from the author's findings. Where traceability matters, record source versions, model settings, human revisions and approvals. If output enters regulated research, manufacturing or submission processes, the responsible quality and regulatory teams should determine applicable validation and change-control requirements.
RAG knowledge retrieval can help locate evidence in approved material. Retrieving a passage does not establish its suitability for the current purpose. Testing a bounded MVP does not automatically exempt the work from data or quality requirements.
Care settings: define staff takeover
Assess care-record drafts separately from scheduling notifications. Drafts need content checks and clear responsibility; notifications need recipient checks and handling for failure or duplicate messages. An alerting use case also needs a recipient, response process and handling for missed or false alerts. These are planning questions, not measured results in this article.
Limited staffing makes recovery responsibilities particularly relevant. Automatically generated output still takes time to review. Do not assume that every care recipient lacks capacity to consent; determine the applicable processing authority and representation for the individual case. Discussions about workflow integration should include approval points, exception paths and the resulting staff workload.
Taiwan: assess intended use and data separately
TFDA's medical-device introduction describes classification by function, intended use, operation and risk, with an attributes inquiry when status is uncertain. An AI label alone does not establish a uniform registration requirement.
TFDA's August 14, 2025 update to AI/ML computer-aided detection and diagnosis device guidance addresses specific medical devices, rather than certifying general document assistants. Device assessment, research ethics review and institutional approval are separate determinations for the responsible teams.
Taiwan's Personal Data Protection Act, Article 6 sets conditions for processing medical and health data. De-identification is not a universal authorization. Confirm purpose, processing basis, access and retention for the proposed use.
Four agreements before handover
- Scope: permitted inputs and outputs, including decisions the system must not make.
- Review: who checks sources, handles omissions and accepts or rejects results.
- Evidence: representative cases, failure types, human revisions and comparison with the existing process.
- Operation: permissions, version changes, incident handling, suspension and manual takeover.
Agree these before expanding the task. Completed development, active use and satisfaction of applicable requirements are separate judgments, each requiring its own evidence.
Summarize this page with AI
Related posts

Start with one workflow.
Agree on the next step.
Leave your contact details and question type. We will follow up by email to understand the work and discuss scope.